110965-79-2

Upstream product

• 110965-77-0 (3R,5S)-3,5-Dimethyl-heptanoic acid (1R,2S,4S)-1-[(dicyclohexylsulfamoyl)-methyl]-7,7-dimethyl-bicyclo[2.2.1]hept-2-yl ester 
• 110991-03-2 (Diethoxy-phosphoryl)-acetic acid (1R,2S,4S)-1-[(dicyclohexylsulfamoyl)-methyl]-7,7-dimethyl-bicyclo[2.2.1]hept-2-yl ester 
• 125382-45-8 Bromo-acetic acid (1R,2S,4S)-1-[(dicyclohexylsulfamoyl)-methyl]-7,7-dimethyl-bicyclo[2.2.1]hept-2-yl ester 
• 2490-12-2 (3R,5S)-3,5-Dimethyl-heptanoic acid 
• 91526-50-0 (3R,5S)-3,5-Dimethyl-heptanal 
• 99295-72-4 (+)-(1R,2S,4S)-N,N-dicyclohexyl-7,7-dimethyl-2-hydroxybicyclo[2.2.1]heptane-1-methanesulfonamide 
• 1565-80-6 (2S)-2-methyl-1-butanol 
• 917-54-4 methyllithium 
• 110965-78-1 (E)-(5R,7S)-5,7-Dimethyl-non-2-enoic acid (1R,2S,4S)-1-[(dicyclohexylsulfamoyl)-methyl]-7,7-dimethyl-bicyclo[2.2.1]hept-2-yl ester 

Relevant academic research and scientific papers

ENANTIOSELECTIVE SYNTHESIS OF THE ALLEGED STRUCTURE OF NORPECTINATONE

The deoxypolypropionate 13 was synthesized from (S)-2-methyl-1-butanol by a reaction sequence featuring two highly ?-face selective organocopper/enoate additions 1 -> 4 and 7 -> 8.Neither 13 (the configuration of which was comfirmed by X-ray analysis of 8